Bile acid sequestrants: mechanisms of action on bile acid and cholesterol metabolism

[1]  K. Einarsson,et al.  Effect of cholestyramine treatment on biliary lipid secretion rates in normolipidaemic men , 1991, Journal of internal medicine.

[2]  K. Einarsson,et al.  Regulation of hepatic cholesterol metabolism in humans: stimulatory effects of cholestyramine on HMG-CoA reductase activity and low density lipoprotein receptor expression in gallstone patients. , 1990, Journal of lipid research.

[3]  K. Einarsson,et al.  Increased turnover of very low density lipoprotein triglyceride during treatment with cholestyramine in familial hypercholesterolaemia , 1990, Journal of internal medicine.

[4]  K. Einarsson,et al.  Bile acid synthesis in humans: regulation of hepatic microsomal cholesterol 7 alpha-hydroxylase activity. , 1989, Gastroenterology.

[5]  K. Einarsson,et al.  On the saturation of the cholesterol 7 alpha-hydroxylase in human liver microsomes. , 1989, Journal of lipid research.

[6]  K. Einarsson,et al.  Mechanism of intestinal formation of deoxycholic acid from cholic acid in humans: evidence for a 3-oxo-delta 4-steroid intermediate. , 1989, Journal of lipid research.

[7]  K. Einarsson,et al.  On the possible use of the serum level of 7 alpha-hydroxycholesterol as a marker for increased activity of the cholesterol 7 alpha-hydroxylase in humans. , 1987, Journal of lipid research.

[8]  M. Brown,et al.  A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.

[9]  J. Dietschy,et al.  Rates of low density lipoprotein uptake and cholesterol synthesis are regulated independently in the liver. , 1985, Journal of lipid research.

[10]  M. Rudling,et al.  A simple binding assay for the determination of low-density lipoprotein receptors in cell homogenates. , 1985, Biochimica et biophysica acta.

[11]  R. Heller,et al.  3-hydroxy-3-methylglutaryl coenzyme A reductase in human liver microsomes: active and inactive forms and cross-reactivity with antibody against rat liver enzyme. , 1984, Journal of lipid research.

[12]  S. Hayakawa.  [Enterohepatic circulation of bile acids]. , 1984, Nihon rinsho. Japanese journal of clinical medicine.

[13]  K. Einarsson,et al.  Cholestyramine treatment reduces postprandial but not fasting serum bile acid levels in humans. , 1982, Gastroenterology.

[14]  C. Packard,et al.  The hepatobiliary axis and lipoprotein metabolism: effects of bile acid sequestrants and ileal bypass surgery. , 1982, Journal of lipid research.

[15]  K. Einarsson,et al.  Hepatic uptake of bile acids in man. Fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum. , 1982, The Journal of clinical investigation.

[16]  S. Grundy,et al.  Effects of interruption of the enterohepatic circulation of bile acids on the transport of very low density-lipoprotein triglycerides. , 1982, Metabolism: clinical and experimental.

[17]  H. G. Morgan,et al.  Cholestyramine promotes receptor-mediated low-density-lipoprotein catabolism. , 1980, The New England journal of medicine.

[18]  K. Einarsson,et al.  Effects of cholestyramine and chenodeoxycholic acid on the metabolism of endogenous triglyceride in hyperlipoproteinemia. , 1978, Journal of lipid research.

[19]  S. Grundy,et al.  Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia. , 1977, The Journal of laboratory and clinical medicine.

[20]  G. Schonfeld,et al.  The effects of colestipol on the metabolism of very-low-density lipoproteins in man. , 1976, The Journal of laboratory and clinical medicine.

[21]  S. Grundy,et al.  Changes in plasma triglyceride metabolism during withdrawal of bile. , 1976, Metabolism: clinical and experimental.

[22]  K. Einarsson,et al.  Evidence for the absorption of bile acids in the proximal small intestine of normo- and hyperlipidaemic subjects. , 1976, Gut.

[23]  A. Hofmann.  The enterohepatic circulation of bile acids in man. , 1976, Advances in internal medicine.

[24]  S. Phillips,et al.  Active and passive bile acid absorption in man. Perfusion studies of the ileum and jejunum. , 1974, The Journal of clinical investigation.

[25]  K. Einarsson,et al.  The Effect of Cholestyramine on the Elimination of Cholesterol as Bile Acids in Patients with Hyperlipoproteinaemia Type II and IV , 1974, European Journal of Clinical Investigation.

[26]  J. Garbutt,et al.  Effect of cholestyramine on bile acid metabolism in normal man. , 1972, The Journal of clinical investigation.

[27]  S. Grundy,et al.  Interruption of the enterohepatic circulation of bile acids in man: comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism. , 1971, The Journal of laboratory and clinical medicine.

[28]  D. Small,et al.  Effects of controlled interruption of the enterohepatic circulation of bile salts by biliary diversion and by ileal resection on bile salt secretion, synthesis, and pool size in the rhesus monkey. , 1970, The Journal of clinical investigation.

[29]  T. R. Bates,et al.  Quantification of the binding tendencies of cholestyramine. I. Effect of structure and added electrolytes on the binding of unconjugated and conjugated bile-salt anions. , 1969, Journal of pharmaceutical sciences.

[30]  M. Siperstein,et al.  Cholesterol metabolism in man. , 1955, The Journal of clinical investigation.

[31]  Michael S. Roberts,et al.  Enterohepatic Circulation , 2002, Clinical pharmacokinetics.

[32]  R. Havel.  Functional activities of hepatic lipoprotein receptors. , 1986, Annual review of physiology.

[33]  K. Einarsson,et al.  Bile acid synthesis in man: assay of hepatic microsomal cholesterol 7 alpha-hydroxylase activity by isotope dilution-mass spectrometry. , 1986, Journal of lipid research.

[34]  I. Björkhem.  Chapter 9 Mechanism of bile acid biosynthesis in mammalian liver , 1985 .

[35]  K. Einarsson,et al.  9 – Regulation of HMG-CoA Reductase in Human Liver , 1985 .

[36]  E. Andersén.  The effect of cholestyramine on bile acid kinetics in healthy controls. , 1979, Scandinavian journal of gastroenterology.

[37]  O. Faergeman,et al.  Binding of bile acids to anion-exchanging drugs in vitro. , 1978, Scandinavian journal of gastroenterology.